Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Connective and Soft Tissue

Explore clinical trials studying Neoplasms, Connective and Soft Tissue. Study availability and eligibility vary by location and protocol.

2,726 public trials 585 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Connective and Soft Tissue trial results

Active, Not Recruiting

Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors

NCT02574728

Conditions
Brain Diseases, Brain Neoplasms, Cancer, +38 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Nemours/Alfred I. duPont Hospital for Children Wilmington, Delaware, United States
  • Children's Healthcare of Atlanta-Egleston Atlanta, Georgia, United States
  • Children's Healthcare of Atlanta, Scottish Rite Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

Olaparib With Ceralasertib in Recurrent Osteosarcoma

NCT04417062

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +5 more
Locations
  • UCSF Benioff Children's Hospital; UCSF Pediatrics Hematology Oncology San Francisco, California, United States
  • Dana Farber Cancer Institite Boston, Massachusetts, United States
  • Memorial Sloan Kettering New York, United States
  • MD Anderson Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs

NCT04288375

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations
  • Memorial Sloan Kettering Basking Ridge (All protocol activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (All protocol activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss

NCT04065269

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +26 more
Locations
  • The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • University of Montreal Hospital Centre Montreal, Quebec, Canada
  • Royal United Hospital Bath, United Kingdom
View Trial Details
Active, Not Recruiting

Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy

NCT03474094

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +2 more
Locations
  • Institut Bergonie Bordeaux, France
  • Centre Oscar Lambret Lille, France
  • Centre Léon Bérard Lyon, France
  • Institut Claudius Regaud Toulouse, France
View Trial Details

Related conditions